Close
Company Search
Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Poolbeg Pharma (POLB) Share Price

Price 6.15p on 27-07-2026 at 18:35:06
Change 0.00p 0%
Buy 6.20p
Sell 6.10p
Add to Watchlist
Add to Portfolio
Add to Quickpicks
Last Trade: Sell 20,000.00 at 6.14p
Day's Volume: 885,189
Last Close: 6.15p
Open: 6.15p
ISIN: GB00BKPG7Z60
Day's Range 6.15p - 6.15p
52wk Range: 2.55p - 8.60p
Market Capitalisation: £43.36m
VWAP: 6.166121p
Shares in Issue: 705.10m

Sector: Medicine and Biotech

Listed In: FTSE AIM All-Share,

Poolbeg Pharma (POLB) Latest Trades

Buy/Sell Volume Trade Prc Trade Type Trade Time
Sell* 20,000 6.14p Ordinary
 16:28:57 - 27-Jul-26
Buy* 11,670 6.20p Ordinary
 16:28:45 - 27-Jul-26
Buy* 1,209 6.20p Ordinary
 16:15:12 - 27-Jul-26
Buy* 20,184 6.168p Ordinary
 15:34:41 - 27-Jul-26
Sell* 150 6.10p Ordinary
 15:04:36 - 27-Jul-26
Sell* 30,000 6.14p Ordinary
 15:03:12 - 27-Jul-26
Buy* 8,054 6.168p Ordinary
 14:46:01 - 27-Jul-26
Sell* 1,500 6.14p Ordinary
 14:15:06 - 27-Jul-26
Sell* 4,802 6.14p Ordinary
 14:09:47 - 27-Jul-26
Buy* 115,547 6.168p Ordinary
 14:05:04 - 27-Jul-26
See more Poolbeg Pharma trades

Poolbeg Pharma (POLB) Share Price History

Time period:
to
Date Open High Low Close Volume
27th Jul 2026 (Mon) 6.15 6.15 6.15 6.15 885,189
24th Jul 2026 (Fri) 6.15 6.15 6.15 6.15 342,589
23rd Jul 2026 (Thu) 6.15 6.15 6.15 6.15 446,257
22nd Jul 2026 (Wed) 6.25 6.10 6.10 6.10 1,039,181
21st Jul 2026 (Tue) 6.20 6.25 6.20 6.20 3,033,789
20th Jul 2026 (Mon) 6.20 6.20 6.15 6.16 2,572,142
17th Jul 2026 (Fri) 6.15 6.15 6.15 6.15 2,673,237
16th Jul 2026 (Thu) 6.26 6.26 6.10 6.15 4,810,359
15th Jul 2026 (Wed) 6.05 6.30 6.15 6.30 5,019,489
14th Jul 2026 (Tue) 6.25 6.25 6.00 6.05 27,046,903
13th Jul 2026 (Mon) 7.00 7.25 7.00 7.00 1,624,551
10th Jul 2026 (Fri) 7.05 7.28 7.00 7.00 895,163
9th Jul 2026 (Thu) 6.95 7.22 6.95 7.05 1,161,735
8th Jul 2026 (Wed) 6.95 7.18 6.95 7.10 280,141
7th Jul 2026 (Tue) 6.90 6.90 6.90 6.90 1,082,787
6th Jul 2026 (Mon) 6.90 6.90 6.90 6.90 43,402
3rd Jul 2026 (Fri) 7.00 7.00 6.75 6.85 1,907,872
2nd Jul 2026 (Thu) 6.85 6.85 6.75 6.75 725,553
1st Jul 2026 (Wed) 6.85 6.85 6.85 6.85 481,313
30th Jun 2026 (Tue) 6.85 6.85 6.85 6.85 490,384
29th Jun 2026 (Mon) 6.75 6.75 6.75 6.75 548,977
See more Poolbeg Pharma price history

Poolbeg Pharma (POLB) Regulatory News

Date Source Headline
23rd Jul 2026 11:05 am RNS Notification of major holdings
22nd Jul 2026 7:00 am RNS Notification of Major Holdings
21st Jul 2026 7:00 am RNS-R Notice of Allowance for POLB 001 patent in Israel
14th Jul 2026 7:00 am RNS Placing to raise £3.5 million
13th Jul 2026 7:00 am RNS First patient dosed in POLB 001 TOPICAL trial
30th Jun 2026 7:00 am RNS-R POLB 001 patent granted in South Africa
16th Jun 2026 7:05 am RNS European patent granted for POLB 001 in CRS
16th Jun 2026 7:00 am RNS PDMR Notification
11th Jun 2026 7:05 am RNS Preclinical data posters presented at EHA Congress
11th Jun 2026 7:00 am RNS Poolbeg Announces POLB 001 TOPICAL Site Activation
See more Poolbeg Pharma regulatory news

Poolbeg Pharma (POLB) Share News

TRADING UPDATES: Zenith private placement; CyanConnode revised offer

21st Jul 2026 19:34

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

IN BRIEF: Poolbeg Pharma raises GBP3.5 million in share placing

15th Jul 2026 06:59

Poolbeg Pharma PLC - London-based biopharmaceutical firm focused on cancer immunotherapy - Raises GBP3.5 million from a placing of 58.3 million new shares at 6 pence each. The placing price is a discount of 16% from the stock's closing market price on Monday. The funds will be used to fund two drug trials through to completion, extending Poolbeg's cash runway into the second quarter of 2028. The share placing is run by broker Oak Securities. "This successful fundraise is a great market endorsement of Poolbeg, our strategy and pipeline," says Chief Executive Officer Jeremny Skillington. "Not only does it extend our expected cash runway into Q2 2028, but it strengthens the company's position in ongoing partnering discussions." Read More

WINNERS & LOSERS: Ironveld's plant in production; Headlam revenue down

14th Jul 2026 11:16

(Alliance News) - The following are the leading risers and fallers among London Main Market small-cap and AIM stocks on Tuesday. Read More

TRADING UPDATES: Zenith Energy in Rome buy; Concurrent revenue rises

13th Jul 2026 11:42

(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Monday and not separately reported by Alliance News: Read More

EARNINGS AND TRADING: IG Design restores dividend and launches buyback

16th Jun 2026 15:32

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More

See more Poolbeg Pharma news
FTSE 100 Latest
Value10,781.75
Change45.52

Login to your account

Forgot Password?

Not Registered